Gilead boosts oncology pipeline with XinThera acquisition

Published on May 12, 2023

Gilead Sciences, Inc. has announced the acquisition of all outstanding shares of XinThera, a privately held biotech company in San Diego.  Gilead said the acquisition complements its existing clinical development priorities by adding additional pipeline assets for well-validated targets in oncology and inflammation. Through the acquisition, Gilead gains the rights to a portfolio of small […]

The post Gilead boosts oncology pipeline with XinThera acquisition appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Continue reading on website
Other news

Life Biosciences and Forge Biologics Sign Gene Therapy Manufacturing Partnership Agreement

May 12, 2023
Life Biosciences and Forge Biologics entered into a manufacturing partnership to help advance Life Bio’s partial epigenetic reprogramming platform to address aging-related diseases, including its lead program targeting ophthalmic indications.“Life Bio is an emerging leader in the development of novel therapies for aging-related diseases, and we are thrilled to serve as their cGMP manufacturing par

£77m funding awarded for new zero-emission vehicle projects

May 12, 2023
Seven projects across the country that will support more than 4,400 jobs over the next decade are to share £77m of joint government and industry funding to develop clean transport technologies. The schemes include work on battery-powered buses, a hydrogen-powered version of the Ford Transit van, and a project to develop a hydrogen fuel-cell range extender for specialist electric vehicles in...Sour